![]() Addex Therapeutics Addex Therapeutics, a development-stage biopharmaceutical company, discovers small-molecule pharmaceutical products. | ![]() IRLAB Therapeutics IRLAB Therapeutics is a biotechnology company focused on Parkinson's disease (PD). | ![]() AlzeCure Pharma AlzeCure Pharma is a company developing diagnostics and therapeutics for Parkinson’s, Alzheimer’s diseases, and related neurodegenerative disorders. | |
Founding Date | Founding Date 2002 | Founding Date 2013 | Founding Date 2012 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Plan-les-Ouates, CH HQ San Francisco, US | Locations Göteborg, SE HQ | Locations Huddinge, SE HQ |
Employees | Employees 23 | Employees 30 | Employees 11 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 63.7 m | Valuation ($) 14.9 m |
Financial | |||
Revenue (est.) | Revenue (est.) CHF30k (FY, 2025) | Revenue (est.) kr57.5m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit CHF173k (FY, 2025) | Gross profit kr62.8m (FY, 2025) | Gross profit kr1.6m (FY, 2025) |
Net income | Net income (CHF6.8m) (FY, 2025) | Net income (kr110m) (FY, 2025) | Net income (kr47.7m) (FY, 2025) |

IRLAB Therapeutics is a biotechnology company focused on Parkinson's disease (PD).
View company
AlzeCure Pharma is a company developing diagnostics and therapeutics for Parkinson’s, Alzheimer’s diseases, and related neurodegenerative disorders.
View company